Platelet-Derived Growth Factor as a Therapeutic Target for Systemic Autoimmune Diseases
Drug Target Insights · 2007
DOI: 10.1177/117739280700200006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Target Insights, 2007. Verfasst von Hideto Kameda und 2 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Some systemic rheumatic diseases and disorders, especially fibrotic and vascular disorders, are often refractory to corticosteroid therapy. Recently, ever accumulating evidence suggests that platelet-derived growth factor (PDGF) is involved in those refractory diseases. Imatinib mesylate inhibits the activation of PDGF receptor as well as c-Abl, Bcr-Abl and c-Kit tyrosine kinases. It has therefore been widely used for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors. Imatinib effectively suppresses the activation and proliferation of fibroblasts, mesangial cells and smooth muscle cells both in vitro and in vivo. Additionally, it has recently been reported that some patients with rheumatoid arthritis or idiopathic pulmonary arterial hypertension demonstrated a good clinical response to imatinib therapy. Imatinib may therefore overcome the limitations of current therapeutic strategy with corticosteroids and immunosuppressive agents for refractory diseases, such as systemic sclerosis and interstitial lung diseases, without clinical intolerability.
Zitieren
APA
Kameda, H., Suzuki, M., & Takeuchi, T. (2007). Platelet-Derived Growth Factor as a Therapeutic Target for Systemic Autoimmune Diseases. Drug Target Insights. https://doi.org/10.1177/117739280700200006
Vancouver
Kameda H, Suzuki M, Takeuchi T. Platelet-Derived Growth Factor as a Therapeutic Target for Systemic Autoimmune Diseases. Drug Target Insights. 2007. doi:10.1177/117739280700200006
BibTeX
@article{Kameda2007,
author = {Kameda, Hideto and Suzuki, Miyuki and Takeuchi, Tsutomu},
title = {Platelet-Derived Growth Factor as a Therapeutic Target for Systemic Autoimmune Diseases},
journal = {Drug Target Insights},
year = {2007},
doi = {10.1177/117739280700200006}
}
EUVIMED